Organizations Filed Purposes:
OVER 2 BILLION PEOPLE LIVE WITHOUT ACCESS TO MEDICINES. A ROOT CAUSE OF THE HIGH COST OF MEDICINES IS THE OUTDATED PATENT SYSTEM, WHICH IS IMBALANCED - FAVORING PRIVATE INTERESTS OVER PUBLIC GOOD. CURRENTLY THE SYSTEM ENABLES DRUG COMPANIES TO GET HUNDREDS OF PATENTS - EFFECTIVELY DOUBLING THE LENGTH OF THEIR MONOPOLY. THIS ALLOWS COMPANIES TO SET PRICES FAR TOO HIGH FOR FAR TOO LONG. TO SOLVE THE DRUG PRICING PROBLEM, WE MUST SOLVE THE DRUG PATENT PROBLEM. BY REIMAGINING THE PATENT SYSTEM, WE CAN ENSURE PEOPLE CAN GET THE LIFESAVING MEDICINE THEY NEED TO GET WELL.
I-MAK'S MISSION IS TO INCREASE GLOBAL ACCESS TO AFFORDABLE LIFE-SAVING MEDICINES BY RESTORING INTEGRITY TO THE PATENT SYSTEM. I-MAK ENVISIONS A WORLD IN WHICH LIFESAVING MEDICINES ARE READILY AVAILABLE WITHOUT EXCESSIVE INDIVIDUAL OR SOCIAL COST.
IN 2019, I-MAK'S PUBLIC EDUCATION PROGRAMMING WORKED TOWARDS THE GOAL OF MAKING THE ROLE OF PATENTS CENTRAL IN THE DRUG PRICING CONVERSATION. WE CONDUCTED EXTENSIVE ORIGINAL RESEARCH INTO THE PATENT ESTATES OF SEVERAL BESTSELLING DRUGS TO USE AS EXAMPLES OF HOW THE SYSTEM IS CURRENTLY WORKING. THROUGH TARGETED COMMUNICATIONS AND STAKEHOLDER ENGAGEMENT, WE REVEALED THE ANTI-COMPETITIVE STRATEGIES USED BY BRANDED PHARMACEUTICAL COMPANIES AND THE COST TO OUR SOCIETY. WE EDUCATED OVER 7,300 PEOPLE ABOUT THE CONNECTION OF PATENTS AND PRICING THROUGH HIGH IMPACT SPEAKING ENGAGEMENTS. OUR RESEARCH WAS CITED IN OVER 40 MEDIA ARTICLES, INCLUDING THE NEW YORK TIMES, NBC NEWS, AND DOCUMENTARIES ON AL JAZEERA AND CHANNEL 4; AND IN SEVEN CONGRESSIONAL HEARINGS. WE CONTINUED TO MANAGE SIX STRATEGIC LITIGATION CASES WORLDWIDE.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Tahir Amin | CO-EXECUTIVE DIRECTOR/SECRETARY | 60 | $186,000 |
| Priti Radha Krishtel | CO-EXECUTIVE DIRECTOR/PRESIDENT | 60 | $169,486 |
| Anne Lebleu | DIRECTOR | 2 | $0 |
| Amanda Parsons | DIRECTOR | 2 | $0 |
| Lara Galinksy | DIRECTOR | 2 | $0 |
| Renu Saini | DIRECTOR | 2 | $0 |
| Reena Abraham | DIRECTOR | 2 | $0 |
| Amy Herskovitz | DIRECTOR | 2 | $0 |
| Monica Mehta | DIRECTOR | 2 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202042839349301434_public.xml